Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

LADD MEMORIAL HOSPITAL

NPI: 1467560227 · OSCEOLA, WI 54020 · Critical Access Hospital Clinic/Center · NPI assigned 08/29/2006

$1.21M
Total Medicaid Paid
46,457
Total Claims
33,605
Beneficiaries
67
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialMACKEN-MARBLE, KELLY (CEO)
NPI Enumeration Date08/29/2006

Related Entities

Other providers sharing the same authorized official: MACKEN-MARBLE, KELLY

ProviderCityStateTotal Paid
LADD MEMORIAL HOSPITAL OSCEOLA WI $464K
UNITED SURGEONS, LLC MISHAWAKA IN $4K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 8,444 $130K
2019 5,663 $119K
2020 3,477 $110K
2021 6,505 $225K
2022 7,151 $203K
2023 7,605 $231K
2024 7,612 $186K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99282 Emergency department visit for the evaluation and management, low to moderate severity 1,526 1,232 $290K
99281 Emergency department visit for the evaluation and management, self-limited or minor 1,371 1,116 $230K
99283 Emergency department visit for the evaluation and management, moderate severity 1,175 921 $179K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 1,791 1,425 $63K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 2,582 2,263 $61K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 672 623 $56K
99284 Emergency department visit for the evaluation and management, high severity 542 377 $45K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 1,509 1,291 $43K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 1,639 647 $33K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 4,048 2,954 $22K
80053 Comprehensive metabolic panel 2,704 2,068 $22K
80048 Basic metabolic panel (calcium, ionized) 2,398 1,744 $19K
71046 Radiologic examination, chest; 2 views 499 386 $18K
84443 Thyroid stimulating hormone (TSH) 1,208 1,062 $16K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 1,086 824 $16K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 370 316 $13K
83036 Hemoglobin; glycosylated (A1C) 910 779 $7K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 23 13 $7K
85610 929 398 $6K
81003 1,133 931 $6K
96361 Intravenous infusion, hydration; each additional hour 22 15 $6K
80061 Lipid panel 473 393 $5K
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 418 319 $5K
85027 896 726 $4K
87631 35 26 $4K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 193 169 $4K
36415 Collection of venous blood by venipuncture 7,057 5,324 $3K
81025 338 275 $3K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 142 126 $3K
G0463 Hospital outpatient clinic visit for assessment and management of a patient 900 553 $2K
81001 567 455 $2K
87086 Culture, bacterial; quantitative colony count, urine 316 260 $2K
97530 Therapeutic activities, direct patient contact, each 15 minutes 98 52 $2K
82728 145 120 $1K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) 83 40 $1K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination 58 30 $944.21
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 386 293 $896.24
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 43 34 $822.67
J3490 Unclassified drugs 1,634 397 $775.72
J2405 Injection, ondansetron hydrochloride, per 1 mg 606 383 $656.19
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 14 13 $643.59
90686 81 78 $622.18
86140 169 126 $554.10
83735 146 111 $500.69
88305 Level IV - Surgical pathology, gross and microscopic examination 93 26 $406.79
85018 173 138 $393.27
36416 717 318 $320.19
80306 18 14 $243.70
87634 29 27 $211.46
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 29 27 $202.93
87210 36 26 $154.60
83690 35 24 $114.33
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 13 12 $108.60
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 281 150 $98.09
96375 Therapeutic injection; each additional sequential IV push 171 103 $91.65
J2704 Injection, propofol, 10 mg 658 268 $76.00
87081 13 12 $68.84
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) 472 260 $12.28
J7120 Ringers lactate infusion, up to 1000 cc 340 203 $7.83
J1170 Injection, hydromorphone, up to 4 mg 38 13 $2.00
0353U 13 12 $0.00
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg 198 132 $0.00
J1885 Injection, ketorolac tromethamine, per 15 mg 56 39 $0.00
J2250 Injection, midazolam hydrochloride, per 1 mg 48 39 $0.00
J3010 Injection, fentanyl citrate, 0.1 mg 38 29 $0.00
G0008 Administration of influenza virus vaccine 23 20 $0.00
J1100 Injection, dexamethasone sodium phosphate, 1 mg 30 25 $0.00